SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : British Biotech (BBIOY)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Henry Niman who wrote (5)10/25/1996 12:44:00 AM
From: Philip H. Lee   of 41
 
Up 3 1/8 to 35 3/4. Marismastat MMPI trial results coming up soon. Anyone have an evaluation on BBIOY's drug? The MMPI class of drugs could radically change cancer treatment techniques if successful, I've read.

Bloomberg reports that BBIOY's MMPI drug is the furthest along in the trial process, ahead of Agouron and other. If I'm not mistaken, it said BBIOY should have 1-2 yr lead on MMPI competitors if Marismastat proves succesful.

Philip
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext